abagovomab 25
abciximab 24
abituzumab 23
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 10
afasevikumab 12
alacizumab_pegol 8
alemtuzumab 22
alirocumab 16
amatuximab 33
andecaliximab 21
anifrolumab 14
anrukinzumab 17
aprutumab 16
aprutumab_ixadotin 16
arcitumomab 16
ascrinvacumab 4
atezolizumab 14
atinumab 14
avelumab 9
basiliximab 25
bavituximab 27
begelomab 22
benralizumab 24
bevacizumab_beta 19
bezlotoxumab 11
bimagrumab 13
bleselumab 9
blinatumomab 23
blosozumab 29
bococizumab 17
brazikumab 18
brentuximab_vedotin 22
briakinumab 19
brodalumab 7
brolucizumab 27
brontictuzumab 25
burosumab 15
cabiralizumab 24
camrelizumab 13
canakinumab 22
cantuzumab_ravtansin 33
carlumab 13
carotuximab 13
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 25
cetiximab 31
citatuzumab_bogatox 27
cixutumumab 22
clivatuzumab_tetraxetan 15
codrituzumab 21
conatumumab 10
concizumab 18
crenezumab 19
crizanlizumab 23
crotedumab 19
dacetuzumab 21
daclizumab 14
dalotuzumab 26
dapirolizumab_pegol 23
daratumumab 12
dectrekumab 10
demcizumab 20
denosumab 8
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 22
dinutuximab 30
diridavumab 21
domagrozumab 16
drozitumab 13
duligotuzumab 20
durvalumab 8
dusigitumab 18
efalizumab 34
efungumab 22
eldelumab 14
elezanumab 17
elgemtumab 10
elotuzumab 15
emactuzumab 15
emapalumab 22
emibetuzumab 18
enavatuzumab 23
enfortumab_vedotin 14
enoblituzumab 17
enokizumab 25
enoticumab 18
ensituximab 23
eptinezumab 13
erenumab 18
etaracizumab 14
etrolizumab 22
evinacumab 20
evolocumab 13
farletuzumab 3
fasinumab 16
fezakinumab 20
fibatuzumab 9
ficlatuzumab 23
firivumab 25
flanvotumab 15
fletikumab 20
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 15
ganitumab 19
gantenerumab 13
gemetuzumab 25
gemtuzumab2 19
gemtuzumab 21
gevokizumab 21
girentuximab 23
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 28
ibritumomab 19
icrucumab 11
idarucizumab 22
ifabotuzumab 9
imalumab 15
imgatuzumab 20
inclacumab 20
indatuximab_ravtansin 24
indusatumab 15
inebilizumab 22
intetumumab 6
iodine_girentuximab 29
ipilimumab 3
iratumumab 8
isatuximab 23
itolizumab 22
ixekizumab 24
labetuzumab_govitecan 20
lambrolizumab 27
lampalizumab 24
lanadelumab 19
landogrozumab 15
laprituximab 26
lebrikizumab 30
lendalizumab 24
lenzilumab 16
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 28
lirilumab 21
lodelcizumab 15
lokivetmab 16
lorvotuzumab_mertansin 17
lucatumumab 29
lumretuzumab 19
lupartumab 17
lutikizumab 16
margetuximab 30
milatuzumab 27
mirvetuximab 28
mirvetuximab_soravtansin 28
modotuximab 36
mogamulizumab 22
monalizumab 18
motavizumab 25
moxetumomab_pasudotox 19
namilumab 19
naratuximab 23
naratuximab_emtansin 23
narnatumab 15
navicixizumab2 25
navicixizumab 22
navivumab 30
necitumumab 10
nemolizumab 25
nesvacumab 14
nivolumab 12
obiltoxaximab 19
obinutuzumab 30
ocaratuzumab 20
ofatumumab 14
olaratumab 14
olokizumab 24
omalizumab 17
onartuzumab 22
ontuxizumab 20
opicinumab 13
orticumab 11
otelixizumab 36
oxelumab 10
ozanezumab 25
pamrevlumab 11
panobacumab 19
parsatuzumab 27
pasotuxizumab 17
pateclizumab 13
patritumab 12
pembrolizumab 27
perakizumab 22
pidilizumab 14
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 22
polatuzumab_vedotin 20
ponezumab 26
prezalumab 14
pritoxaximab 32
quilizumab 19
racotumomab 26
radretumab 13
ralpancizumab 22
ramucirumab 11
ranevetmab 27
ranibizumab 19
refanezumab 20
remtolumab 19
rilotumumab 14
rinucumab 15
risankizumab 30
rituximab 18
rivabazumab 22
robatumumab 20
roledumab 29
romosozumab 21
rontalizumab 20
rosmantuzumab 23
rozanolixizumab 19
sacituzumab 25
sacituzumab_govitecan 25
samalizumab 22
sapelizumab 22
sarilumab 17
secukinumab 14
seribantumab 15
setoxaximab 31
sifalimumab 9
siltuximab 17
simtuzumab 22
sirukumab 9
solanezumab 26
solitomab 21
stamulumab 15
suptavumab 22
suvizumab 15
tabalumab 12
tadocizumab 13
tamtuvetmab 28
tanezumab 21
tarextumab 11
tavolixizumab 12
telisotuzumab 27
teplizumab 16
tesidolumab 19
tezepelumab 22
tigatuzumab 15
tildrakizumab 21
timolumab 13
tisotumab 11
tosatoxumab 28
tositumomab 16
tralokinumab 24
trastuzumab 24
tregalizumab 21
trevogrumab 12
ublituximab 16
urelumab 14
ustekinumab 25
utomilumab 21
vadastuximab 22
vadastuximab_talirin 22
vandortuzumab_vedotin 16
vantictumab 16
vanucizumab2 19
vanucizumab 25
varlilumab 16
vatelizumab 18
vedolizumab 24
veltuzumab 10
vesencumab 9
vorsetuzumab 20
vorsetuzumab_mafodotin 20
vunakizumab 29
xentuzumab 17
zatuximab 36
